GPC3 and hepatocellular carcinoma: Serum AFP values were 6.6 (3.6–14.3) ng/mL in patients with cirrhosis and 19.8 (8.1–74.9) ng/mL in those with HCC (p < 0.001); PIVKA-II values were 46 (33–63) mAU/mL in patients with cirrhosis and 129 (59–361) mAU/mL in those with HCC (p < 0.001); GPC-3 values were 71 (37–163) pg/mL in patients with cirrhosis and 144 (62–246) pg/mL in patients with HCC (p < 0.001).